Upgrade to SI Premium - Free Trial

Abbott Labs (ABT) PT Raised to $63 at Stifel Following 3Q Release

October 18, 2017 5:06 PM
Stifel raised its price target on Abbott Labs (NYSE: ABT) to $63.00 (from $58.00) while maintaining a Buy rating following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles